Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative carboplatin versus standard treatment in advanced ovarian cancer
ISRCTN19184035Phase 2Completed
- Sponsor
- United States Department of Health and Human Services
- Start
- Oct 1997
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
01
Overview
Phase 2, randomised, open-label trial of carboplatin in ovarian cancer (2 arms), sponsored by United States Department of Health and Human Services. Started Oct 1997; status: completed.
02
Drugs
carboplatin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on ISRCTN19184035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN19184035.